Alizapride

Source: Wikipedia, the free encyclopedia.
Alizapride
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration		Oral, IM, IV
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Elimination half-life3 hours
ExcretionRenal
Identifiers
  • N-[(1-Allylpyrrolidin-2-yl)methyl]-6-methoxy-1H-benzo[d][1,2,3]triazole-5-carboxamide
JSmol)
  • C=CCN1CCCC1CNC(=O)c3cc2nn[nH]c2cc3OC
  • InChI=1S/C16H21N5O2/c1-3-6-21-7-4-5-11(21)10-17-16(22)12-8-13-14(19-20-18-13)9-15(12)23-2/h3,8-9,11H,1,4-7,10H2,2H3,(H,17,22)(H,18,19,20) checkY
  • Key:KSEYRUGYKHXGFW-UHFFFAOYSA-N checkY
  (verify)

Alizapride (Litican, Plitican, Superan, Vergentan) is a

prokinetic and antiemetic effects used in the treatment of nausea and vomiting, including postoperative nausea and vomiting. It is structurally related to metoclopramide and other benzamides.[1]

References

  1. PMID 14521717
    .
Retrieved from "https://en.wikipedia.org/w/index.php?title=Alizapride&oldid=1187736268"